Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

BMC Immunology

Volumn 11, Issue , 2010, Pages

  Zhang, Mingjie ^a   Daniel, Sylvester ^a   Huang, Yong ^a,b   Chancey, Caren ^a   Huang, Qingsheng ^a,b   Lei, Ying F ^a,c   Grinev, Andriyan ^a   Mostowski, Howard ^a   Rios, Maria ^a   Dayton, Andrew ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; BLOCKING ANTIBODY; NATURAL KILLER CELL RECEPTOR;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BLOOD RADIATION; CELL ACTIVATION; CELL ACTIVITY; CELL EXPANSION; CELL FUNCTION; CELL STRAIN K 562; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE COUNT; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; VERO CELL; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; BIOSYNTHESIS; CELL PROLIFERATION; CULTURE TECHNIQUE; CYTOTOXICITY; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER CELL; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY; WEST NILE FEVER;

ANTIBODIES, BLOCKING; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOPATHOGENIC EFFECT, VIRAL; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERFERON-GAMMA; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, NATURAL KILLER CELL; VIRUS REPLICATION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 76949089891     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-3     Document Type: Article

References (17)

1. Hallett WH, Murphy WJ. Positive and negative regulation of Natural Killer cells: therapeutic implications. Semin Cancer Biol 2006, 16:367-82. 10.1016/j.semcancer.2006.07.003, 16934486.
2. Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol 2003, 16:259-78. 10.1089/088282403322396082, 14583143.
3. Vargin VV, Semenov BF. Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections. Acta Virol 1986, 30:303-8.
4. Liu Y, King N, Kesson A, Blanden RV, Mullbacher A. Flavivirus infection up-regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro. J Neuroimmunol 1989, 21:157-68. 10.1016/0165-5728(89)90171-9, 2463998.
5. Liu Y, King N, Kesson A, Blanden RV, Mullbacher A. West Nile virus infection modulates the expression of class I and class II MHC antigens on astrocytes in vitro. Ann N Y Acad Sci 1988, 540:483-5. 10.1111/j.1749-6632.1988.tb27143.x, 2849899.
6. King NJ, Maxwell LE, Kesson AM. Induction of class I major histocompatibility complex antigen expression by West Nile virus on gamma interferon-refractory early murine trophoblast cells. Proc Natl Acad Sci USA 1989, 86:911-5. 10.1073/pnas.86.3.911, 286588, 2492666.
7. Momburg F, Mullbacher A, Lobigs M. Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection. J Virol 2001, 75:5663-71. 10.1128/JVI.75.12.5663-5671.2001, 114279, 11356974.
8. Shrestha B, Samuel MA, Diamond MS. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol 2006, 80:119-29. 10.1128/JVI.80.1.119-129.2006, 1317548, 16352536.
9. Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, McKenna D, Le C, Defor TE, Burns LJ, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005, 105:3051-7. 10.1182/blood-2004-07-2974, 15632206.
10. Brand JM, Meller B, Von Hof K, Luhm J, Bahre M, Kirchner H, Frohn C. Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma. Stem Cells Dev 2004, 13:307-14. 10.1089/154732804323099235, 15186726.
11. Meller B, Frohn C, Brand JM, Lauer I, Schelper LF, von Hof K, Kirchner H, Richter E, Baehre M. Monitoring of a new approach of immunotherapy with allogenic (111)In-labelled NK cells in patients with renal cell carcinoma. Eur J Nucl Med Mol Imaging 2004, 31:403-7. 10.1007/s00259-003-1398-4, 14685783.
12. Imai C, Iwamoto S, Campana D. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood 2005, 106:376-83. 10.1182/blood-2004-12-4797, 1895123, 15755898.
13. Arnon TI, Markel G, Mandelboim O. Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol 2006, 16:348-58. 10.1016/j.semcancer.2006.07.005, 16893656.
14. Klingemann HG. Natural killer cell-based immunotherapeutic strategies. Cytotherapy 2005, 7:16-22. 10.1080/14653240510018000, 16040380.
15. Vely F, Vivier E. Natural killer cell receptor signaling pathway. Sci STKE 2005, 2005:cm6. 10.1126/stke.2922005cm6, 16014603.
16. Grinev A, Daniel S, Stramer S, Rossmann S, Caglioti S, Rios M. Genetic Variability of West Nile Virus in US Blood Donors, 2002-2005. Emerg Infect Dis 2008, 14:436-44. 10.3201/eid1403.070463, 2570840, 18325259.
17. Rios M, Zhang MJ, Grinev A, Srinivasan K, Daniel S, Wood O, Hewlett IK, Dayton AI. Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion. Transfusion 2006, 46:659-67. 10.1111/j.1537-2995.2006.00769.x, 16584445.